BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24211084)

  • 1. Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes.
    Sinha P; Thorstad WT; Nussenbaum B; Haughey BH; Adkins DR; Kallogjeri D; Lewis JS
    Oral Oncol; 2014 Jan; 50(1):45-51. PubMed ID: 24211084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soft tissue metastasis in p16-positive oropharynx carcinoma: Prevalence and association with distant metastasis.
    Sinha P; Lewis JS; Kallogjeri D; Nussenbaum B; Haughey BH
    Oral Oncol; 2015 Aug; 51(8):778-86. PubMed ID: 26033471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy.
    Jaber JJ; Murrill L; Clark JI; Johnson JT; Feustel PJ; Mehta V
    Otolaryngol Head Neck Surg; 2015 Aug; 153(2):209-17. PubMed ID: 25917669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
    Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
    Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oropharyngeal squamous cell carcinoma: Prognostic factors for development of distant metastases and oncological outcomes.
    Mattioli F; Lo Manto A; Miglio M; Serafini E; Rossi D; Valerini S; Tonelli R; Fermi M; Pugliese G; Bertolini F; D'Angelo E; Depenni R; Dominici M; Lohr FRH; Marchioni D
    Head Neck; 2023 Jun; 45(6):1406-1417. PubMed ID: 37040549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.
    Barber BR; Biron VL; Klimowicz AC; Puttagunta L; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Oct; 42(1):53. PubMed ID: 24401183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of keratinization with 5-year disease-specific survival in oropharyngeal squamous cell carcinoma.
    Cooper T; Biron VL; Adam B; Klimowicz AC; Puttagunta L; Seikaly H
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):250-6. PubMed ID: 25554966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
    Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
    Rietbergen MM; Brakenhoff RH; Bloemena E; Witte BI; Snijders PJ; Heideman DA; Boon D; Koljenovic S; Baatenburg-de Jong RJ; Leemans CR
    Ann Oncol; 2013 Nov; 24(11):2740-5. PubMed ID: 23946330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity and irregularity of pretreatment
    Cheng NM; Fang YD; Tsan DL; Lee LY; Chang JT; Wang HM; Ng SH; Liao CT; Yang LY; Yen TC
    Oral Oncol; 2018 Mar; 78():156-162. PubMed ID: 29496044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer.
    Sinha P; Kallogjeri D; Gay H; Thorstad WL; Lewis JS; Chernock R; Nussenbaum B; Haughey BH
    Oral Oncol; 2015 May; 51(5):514-20. PubMed ID: 25771076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV- oropharyngeal squamous cell carcinoma: A population-based study.
    Grønhøj C; Jakobsen KK; Jensen DH; Rasmussen J; Andersen E; Friborg J; von Buchwald C
    Oral Oncol; 2018 Aug; 83():127-133. PubMed ID: 30098768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.